COVID-19 Vaccine Trials Hope for Breakthrough By October
Published on May 11, 2020
A main coronavirus vaccine trial — a joint venture between an American and a German company — got underway this week in the United States. Some participants are U.S. medical students. This trial joins others around the world, as pharmaceutical companies compete to discover the breakthrough for COVID-19. VOA’s Carolyn Presutti takes us through what’s being done and how.
About author
Related posts
The most comprehensive national study to date has found that convalescent plasma appears to be safe to use on COVID-19 patients, a promising development in... Continue reading
One-third of hospitalized coronavirus patients have kidney damage and high levels of the virus in the organs, two studies revealOne study found that 36.6% of... Continue reading
In late March, Dottie Hickey got a call from Luxor Nursing & Rehabilitation at Mills Pond, the nursing home where her sister lived. The 79-year-old... Continue reading
Recent Comments